Germany's Protembis raises $10m series-A round
German medical devices company Protembis has raised a $10m series-A round of funding from a consortium of investors including Seed Fonds III.
The syndicate of investors backing the round included US listed medical technology company Abiomed, Seed Fonds III, Mönchengladbach and Coparion, as well as family offices and angel investors.
The company, which develops cerebral protection systems for heart surgery, expects to bring its product to market following this funding round. A first-in-human clinical study has already been conducted, with more testing expected before the market launch.
Company
Founded in 2013, Protembis is a medical devices startup based in Aachen, Germany. It has developed the ProtEmbo cerebral protection system in order to minimise the risk of stroke and other neurological injury in heart-valve interventions. It is a catheter-based filter device that is advanced via the radial artery of the left arm before the start of a transcatheter aortic valve implantation procedure, and removed again at the end of the procedure, in order to prevent the migration of particles to the brain.
People
Protembis – Karl von Mangoldt, Conrad Rasmus (managing directors, founders).
More on Early-stage
Sidekick spinoffs: Insurtech scale-ups attract PE interest
Investment set to break EUR 1.1bn mark this year as sponsors seek for rising stars
World Fund leads EUR 128m raise for quantum computing group IQM
Series-A2 for Finnish startup focused on combating the climate crisis also backed by the EIB
Gorillas raises circa USD 1bn in Delivery Hero-led Series C
New funding comes just seven months after a Series B, with the company doubling in value
French mega-rounds shoot up in 2021
France has already seen as many rounds of EUR 100m and above than in 2019 and 2020 combined, Unquote Data shows
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater